Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Chengdu Origin Biotechnology discovers proteosome inhibitors

March 31, 2020

Jiangsu Chia Tai Tianqing Pharmaceutical Group patents BTK inhibitors

March 31, 2020

New serine-protein kinase ATM inhibitors disclosed by Suzhou Zanrong Pharma

March 31, 2020

Abbisko Therapeutics identifies new fibroblast growth factor receptor inhibitors

March 30, 2020

New geranylgeranyl transferase type 1 inhibitors identified at Bayer

March 30, 2020

Medshine Discovery discovers drugs targeting protein cereblon

March 30, 2020

How lung tumors seed to brain

March 30, 2020

New mouse model of MLL-ENL-driven AML to understand the early stages of leukemogenesis

March 30, 2020

Setting "evolutionary traps" can lure cancer cells into an ambush

March 27, 2020

Merck KGaA identifies new ATR kinase inhibitors

March 27, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 22, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...
In vivo click ADCs could address tumor heterogeneity
BioWorld
Researchers at Washington University in St. Louis have used click chemistry to link a second antibody to a pre-existing antibody-drug conjugate (ADC) in vivo. In...
KBN-2201 reverses key features of Alzheimer’s in mice
BioWorld Science
Researchers from Ajou University School of Medicine reported the preclinical efficacy of KBN-2201 in a mouse model of late-stage Alzheimer’s disease.